Anna Galkin
Impact in
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities
- Oncology top 10%
- Lung Cancer Research Studies
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 4
- Drug Transport and Resistance Mechanisms 2
- Cancer Cells and Metastasis 2
-
- Cancer-related gene regulation 2
- Co-authors
- Pia Vuorela (10 shared papers)Leena Laitinen (4 shared papers)Heikki Vuorela (3 shared papers)Peter G. Schultz (2 shared papers)Adyary Fallarero (3 shared papers)David B. Agus (3 shared papers)Jiqing Jiang (1 shared paper)Yongqin Wan (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (3 papers)Journal of Pharmacy and Pharmacology (3 papers)Natural Product Communications (2 papers)Journal of Clinical Oncology (1 paper)The Prostate (1 paper)
- Partner nations
- FinlandUnited StatesNorway
In The Last Decade
Anna Galkin
25 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 96
- Biochemistry 147
- Oncology 230
- Cancer Research 104
- Immunology 148
- Pulmonary and Respiratory Medicine 212
Countries citing papers authored by Anna Galkin
This map shows the geographic impact of Anna Galkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Galkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Galkin more than expected).
Fields of papers citing papers by Anna Galkin
This network shows the impact of papers produced by Anna Galkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Galkin. The network helps show where Anna Galkin may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Galkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 292 | |
| 2 | 2005 | 113 | |
| 3 | 2004 | 110 | |
| 4 | 2009 | 74 | |
| 5 | 2005 | 74 | |
| 6 | 2008 | 70 | |
| 7 | 2004 | 68 | |
| 8 | 2023 | 63 | |
| 9 | 2022 | 51 | |
| 10 | 2005 | 37 | |
| 11 | 2004 | 32 | |
| 12 | 2021 | 32 | |
| 13 | 2009 | 19 | |
| 14 | 2009 | 15 | |
| 15 | 2006 | 14 | |
| 16 | 2007 | 12 | |
| 17 | 2008 | 11 | |
| 18 | 2020 | 7 | |
| 19 | 2011 | 5 | |
| 20 | 2009 | 4 |
About Anna Galkin
Anna Galkin is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Complementary and alternative medicine, having authored 28 papers that have together received 1.1k indexed citations. Recurring topics across this work include Immune cells in cancer (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Pulmonary Hypertension Research and Treatments (3 papers), Phytochemicals and Antioxidant Activities (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Cancer-related gene regulation (2 papers), Cancer Cells and Metastasis (2 papers) and Computational Drug Discovery Methods (2 papers). The work is most often cited by research in Biochemistry (147 citations), Oncology (230 citations), Cancer Research (104 citations), Immunology (148 citations) and Pulmonary and Respiratory Medicine (212 citations). Anna Galkin has collaborated with scholars based in Finland, United States and Norway. Frequent co-authors include Pia Vuorela, Leena Laitinen, Heikki Vuorela, Peter G. Schultz, Adyary Fallarero, David B. Agus, Jiqing Jiang, Yongqin Wan, Nanxin Li and Fangxian Sun. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Pharmacy and Pharmacology, Natural Product Communications, Journal of Clinical Oncology and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.